Healthcare Services

Outpatient Oncology Infusion Market Developments Influencing Industry Expansion Through 2030

June 2, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Is The Outpatient Oncology Infusion Market’s Market Value Anticipated To Evolve From 2026 To 2030?

The outpatient oncology infusion market has experienced robust expansion over recent years. This market is projected to expand from $14.02 billion in 2025 to reach $15.12 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 7.8%. Historically, this growth has been driven by factors such as a rise in cancer prevalence, the development of outpatient oncology facilities, the uptake of infusion-based treatments, better survival rates necessitating continuous care, and the introduction of sophisticated infusion equipment.

The outpatient oncology infusion market is projected to experience substantial expansion over the forthcoming years. This market is anticipated to reach a valuation of $20.21 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.5%. During the projection period, several factors will drive this growth, including a heightened demand for precision oncology treatments, increased investments in outpatient infusion centers, the proliferation of home-compatible infusion technologies, an intensified emphasis on cost-effective cancer care, and the expanded integration of digital oncology monitoring. Key trends identified for the forecast timeframe encompass a growing transition towards outpatient cancer treatment approaches, the increasing uptake of targeted and immunotherapies, a wider deployment of smart infusion pumps, the expansion of ambulatory infusion centers, and a heightened focus on patient-centric oncology care.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25861&type=smp

What Influential Factors Are Boosting The Outpatient Oncology Infusion Market Demand?

The expanding occurrence of cancer cases is anticipated to boost the growth of the outpatient oncology infusion market. Cancer refers to a range of intricate illnesses characterized by the unchecked proliferation of aberrant cells, which can penetrate adjacent tissues and spread throughout the body. The rise in cancer prevalence is largely attributed to the global aging demographic, given that the risk of developing cancer substantially increases with age. Outpatient oncology infusion provides cancer treatments like chemotherapy, immunotherapy, or targeted therapy in a clinical environment, eliminating the need for hospital admission and enabling patients to continue their daily routines while receiving care. For example, in April 2024, Macmillan Cancer Support, a UK-based charity assisting those affected by cancer with practical, emotional, and financial aid, projected that the population living with cancer in the UK would surpass 3 million currently, escalating to 3.5 million by 2025, 4 million by 2030, and 5.3 million by 2040. Consequently, the growing number of cancer cases is fueling the expansion of the outpatient oncology infusion market.

How Is The Outpatient Oncology Infusion Market Structured Across Different Market Segments?

The outpatient oncology infusion market covered in this report is segmented –

1) By Product: Infusion Pumps, Intravenous Sets, Intravenous Cannulas, Needleless Connectors

2) By Therapy: Chemotherapy, Targeted Therapy, Immunotherapy, Hormonal Therapy

3) By Application: Lung Cancer, Liver Cancer, Breast Cancer, Prostate Cancer, Other Cancers

4) By End-User: Hospitals, Outpatient Clinics, Home Care Settings

Subsegments:

1) By Infusion Pumps: Volumetric Infusion Pumps, Syringe Infusion Pumps, Elastomeric Infusion Pumps, Ambulatory Infusion Pumps, Smart Infusion Pumps

2) By Intravenous Sets: Vented IV Sets, Non-Vented IV Sets, Gravity IV Sets, Pump-Compatible IV Sets, Filtered IV Sets

3) By Intravenous Cannulas: Peripheral IV Cannulas, Central IV Cannulas, Winged IV Cannulas (Butterfly), Closed IV Cannulas, Safety IV Cannulas

4) By Needleless Connectors: Positive Displacement Connectors, Negative Displacement Connectors, Neutral Displacement Connectors, Closed System Transfer Devices (CSTDs), Anti-Reflux Connectors

What Trends Are Driving Changes In The Outpatient Oncology Infusion Market?

Major companies within the outpatient home therapy market are dedicating efforts to developing advanced solutions, such as home rehabilitation programs, with the goal of enhancing patient recovery and improving overall outcomes through personalized, in-home care. Home rehabilitation programs involve structured therapy and recovery plans that patients adhere to at home, often after surgical procedures, injuries, or medical conditions like stroke, joint replacement, or chronic illness. For instance, in October 2024, South Shore VNA (Visiting Nurse Association), a US-based non-profit healthcare organization, launched a home-based outpatient rehabilitation program specifically designed to deliver high-quality rehabilitation services to patients directly within their homes. This program offers a variety of therapies, including physical therapy, occupational therapy, and speech therapy, for individuals recovering from surgery, injury, or managing chronic conditions. The program’s aim is to improve accessibility, convenience, and the overall patient recovery experience, helping them achieve better results while eliminating the need for frequent trips to outpatient clinics.

Who Are The Firms Contributing To The Outpatient Oncology Infusion Market Ecosystem?

Major companies operating in the outpatient oncology infusion market are Medtronic plc, Becton Dickinson and Company, Baxter International Inc., Fresenius Kabi AG, Terumo Corporation, Nipro Corporation, Smiths Medical Inc., ICU Medical Inc., B. Braun Melsungen AG, InfuSystem Holdings Inc., BPL Medical Technologies Private Limited, Angiplast Private Limited, Bio-Med Healthcare Products Private Limited, Lars Medicare Private Limited, Micrel Medical Devices S.A., AKAS Infusions Private Limited, Mais India Medical Devices Private Limited, Wellead Medical Co. Ltd., AdvaCare Pharma USA LLC, Polymed Medical Devices Private Limited.

Access The Complete Outpatient Oncology Infusion Market Report:

https://www.thebusinessresearchcompany.com/report/outpatient-oncology-infusion-global-market-report

Which Region Holds The Largest Share In The Outpatient Oncology Infusion Market?

North America was the largest region in the outpatient oncology infusion market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the outpatient oncology infusion market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Outpatient Oncology Infusion Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=25861&type=smp

Browse Through More Reports Similar to the Global Outpatient Oncology Infusion Market 2026, By The Business Research Company

Home Infusion Therapy Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/home-infusion-therapy-global-market-report

Home Healthcare Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/home-healthcare-global-market-report

Online Therapy Services Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/online-therapy-services-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795